Amgen reported $4.41B in Gross Profit on Sales for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
ALKERMES ALKS:US 210.41M 26.66M
Amgen AMGN:US $ 4411M 626M
Astrazeneca AZN:US 5.4B 495M
Biogen BIIB:US $ 2215.9M 146.1M
Biomarin Pharmaceutical BMRN:US $ 365.86M 39.88M
Bluebird Bio BLUE:US $ 10.51M 1.3M
Bristol Myers Squibb BMY:US $ 8570M 196M
Eli Lilly And LLY:US $ 4927M 793.2M
Gilead Sciences GILD:US $ 5062M 961M
GlaxoSmithKline GSK:LN 5.01B 770M
Glaxosmithkline GSK:US $ 5007M 770M
Intercept Pharmaceuticals ICPT:US $ 80.85M 1.65M
IONIS PHARMACEUT IONS:US $ 109.03M 177.95M
Johnson & Johnson JNJ:US $ 15285M 593M
Merk MRK:US $ 9142M 2116M
Moderna Inc MRNA:US 1.74B 1.18B
Neurocrine Biosciences NBIX:US $ 233.7M 11.3M
Novartis NOVN:VX 8.86B 229M
Novartis NVS:US $ 8861M 229M
Ptc Therapeutics PTCT:US $ 108.84M 5.14M
Puma Biotechnology PBYI:US $ 68.61M 27M
Regeneron Pharmaceuticals REGN:US $ 2220.7M 150.9M
Sarepta Therapeutics SRPT:US $ 124.58M 1.85M
Seattle Genetics SGEN:US $ 267.85M 271.69M
Teva Pharmaceutical TEVA:IT 1.92B 162M
Ultragenyx Pharmaceutical RARE:US $ 94.21M 8.15M
Vertex Pharmaceuticals VRTX:US $ 1531.98M 107.26M
YTE INCY:US $ 580.88M 177.6M